Recombinant follistatin-Fc fusion protein and use in the treatment of Duchenne muscular dystrophy

摘要

The present invention provides methods and compositions for treating muscular dystrophy, particularly Duchenne muscular dystrophy (DMD), among others. In some embodiments, the method according to the present invention reduces intensity, severity, or frequency in at least one DMD symptom or characteristic relative to an individual suffering from or susceptible to DMD. Or administering an effective amount of a recombinant follistatin fusion protein so that onset is delayed. [Selection] Figure 1A